Hasina Outtz Reed

Dr. Hasina Outtz Reed is an Assistant Professor at Weill Cornell Medicine within the Graduate School of Medical Sciences and is affiliated with the Department of Cell & Developmental Biology. She leads the Outtz Reed Lab, which investigates the role of the pulmonary lymphatic vasculature in lung homeostasis and disease.

• Institution: Weill Cornell Medicine
• School: Graduate School of Medical Sciences
• Department: Cell & Developmental Biology
• Academic Rank: Assistant Professor

Dr. Outtz Reed's research focuses on understanding how lymphatic function regulates lung immunity and injury, particularly in diseases such as asthma, fibrosis, and post-transplant complications. Her lab explores mechanisms of lymphatic endothelial-immune crosstalk, the formation of tertiary lymphoid organs (TLOs), lymphatic thrombosis, and the development of inhaled nanoparticles for targeted therapy. Using both mouse models and human tissue, her work has revealed novel insights into fibrin-rich clots in lymphatic vessels as indicators of disease progression and early lymphatic injury.

Her research spans vascular biology, immunology, and pulmonary pathophysiology, with strong translational implications. Though no publications are listed in the provided text, her work appears centered on molecular pathways in lymphatic dysfunction and inflammatory regulation in the lung.

Scientific Awards:

• American Thoracic Society Jo Rae Wright Early Career Investigator Award
• American Society of Clinical Investigation Young Physician Scientist Award

Dr. Outtz Reed has founded the NYC Lymphatic Research Group, demonstrating leadership in her field. She has secured competitive early-career funding and is actively mentoring within the graduate program. Her clinical and research training at the University of Pennsylvania under Dr. Mark Kahn has positioned her at the forefront of vascular and pulmonary research. She is also engaged in science communication through podcast appearances with the American Thoracic Society and the North American Vascular Biology Organization.

She leads an active research lab with current projects on lymphatic thrombosis, TLO formation, lung lymphatic mapping, and nanoparticle-based targeting strategies. Her lab benefits from Weill Cornell’s Core Laboratories Center and institutional research infrastructure.